SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  Division of Cardiology

[Return To Index page]
photo Alaa Shalaby, MD

Associate Professor of Medicine, University of Pittsburgh

Director of Cardiac Electrophysiology, VA Pittsburgh HCS

Attending Electrophysiologist, University of Pittsburgh Medical Center

Email: alaa.shalaby@med.va.gov

Phone: 412-688-6176

Contact
Office: VA Pittsburgh Healthcare System
Cardiology Division, University Drive C
Pittsburgh, PA 15240
 
Phone: 412-688-6176
Fax: 412-688-6904
E-mail: alaa.shalaby@med.va.gov
Education and Training
Education
MD Internal Medicine, Ain Shams University, Cairo, 1986
Masters Degree in Internal Medicine, Ain Shams University, Cairo First Part, 1989
Masters Degree in Internal Medicine, Ain Shams University, Cairo Second and Final Part, 1991
Training
Residency in Internal Medicine, Albert Einstein College of Medicine, NY, 1994
Fellowship in Cardiology, Creighton University, Omaha NE, 1997
Fellowship in Electrophysiology, UCLA Veterans Administration Medical Center, CA, 1998
Research Interest
Dr. Shalaby’s research interests include utilization of implantable devices for and biomarkers of risk for sudden cardiac death as well as utilization of devices for assessment and treatment of congestive heart failure and sleep related breathing disorders.
Clinical Interest
Dr. Shalaby practices cardiology at UPMC Presbyterian. He has participated in clinical trials, including the Ranolazine Implantable Cardioverter-Defibrillator Trial, which looks at how effective the drug ranolazine is in reducing the risk of ventricular arrhythmia and death in people with implantable cardioverter-defibrillators (ICDs); and the Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial which has the overall goal of establishing the appropriate roles for medical and ablative intervention for atrial fibrillation (AF).
Educational Interest
Teaching role as electrophysiology attending at University of Pittsburgh during core curriculum, faculty conference and role review conferences offered to cardiology and electrophysiology fellows by the electrophysiology division. 1999-present

Teaching rounds to University of Pittsburgh fellows and residents at the VA Pittsburgh Healthcare System. 1999-present

Participant in the monthly lectures offered to CCU residents rotating at the VA Pittsburgh Healthcare System. 2010-present
Publications
For my complete bibliography, Click Here.
Selected Publications:
Belperio J, Horwich T, Abraham WT, Fonarow GC, Gorcsan J 3rd, Bersohn MM, Singh JP, Sonel A, Lee LY, Halilovic J, Kadish A, Shalaby AA. Inflammatory Mediators and Clinical Outcome in Patients With Advanced Heart Failure Receiving Cardiac Resynchronization Therapy. Am J Cardiology. 2016; 117(4): 617-25.
Wang NC, Singh M, Adelstein EC, Jain SK, Mendenhall GS, Shalaby AA, Voigt AH, Saba S. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study. Heart Rhythm. 2016; 13(4): 933-42.
Aleong RG, Mulvahill MJ, Halder I, Carlson NE, Singh M, Bloom HL, Dudley SC, Ellinor PT, Shalaby A, Weiss R, Gutmann R, Sauer WH, Narayanan K, Chugh SS, Saba S, London B. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function. J Am Heart Assoc. 2015; 4(8): e001566.
Shariff N, Eby E, Adelstein E, Jain S, Shalaby A, Saba S, Wang NC, Schwartzman D. Response to Letter to the Editor. J Cardiovasc Electyrophysiol. 2015; 26(10): E13.
Shariff N, Eby E, Adelstein E, Jain S, Shalaby A, Saba S, Wang NC, Schwartzman D. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation. J Cardiovasc Electrophysiol. 2015; 26(7): 783-9.
AlJaroudi WA, Refaat MM, Habib RH, Al-Shaar L, Singh M, Gutmann R, Bloom HL, Dudley SC, Ellinor PT, Saba SF, Shalaby A, Weiss R, McNamara DM, Halder I, London B. Genetic Risk Assessment of Defibrillator Events Investigators. Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study). Am J Cardiol. 2015; 115(7): 924-31.
Shalaby AA, Abraham WT, Fonarow GC, Bersohn MM, Gorcsan J 3rd, Lee LY, Halilovic J, Saba S, Maisel A, Singh JP, Sonel A, Kadish A. Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients. Pacing Clin Electrophysiol. 2015; 38(5): 581-90.
Shalaby AA, Refaat M, Lacomis J, Zenati M. Post occlusive left atrial appendage thrombosis with extension into the left atrium. BMJ Case Report. 2014; May 21.
Kini V, Soufi MK, Deo R, Epstein AE, Bala R, Riley M, Groeneveld PW, Shalaby A, Dixit S. Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?. J Am Coll Cardiol. 2014; 63(22): 2388-94.
Shariff N, Singh M, Shalaby A. Acute disseminated intravascular coagulation following ICD lead extraction. BMJ Case Report. 2014; March 5.
Notable Achievements
Marquis' Who's Who of America, 2009